OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm
Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, et al.
Science Advances (2020) Vol. 6, Iss. 50
Open Access | Times Cited: 234

Showing 51-75 of 234 citing articles:

Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Francis R. Hopkins, Melissa Govender, Cecilia Svanberg, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 18

Airborne fine particles drive H1N1 viruses deep into the lower respiratory tract and distant organs
Zheng Dong, Juan Ma, Jiahuang Qiu, et al.
Science Advances (2023) Vol. 9, Iss. 23
Open Access | Times Cited: 17

Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Hoang Van Phan, Alexandra Tsitsiklis, Cole Maguire, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 743
Open Access | Times Cited: 6

CD4+ T cells exhibit distinct transcriptional phenotypes in the lymph nodes and blood following mRNA vaccination in humans
Nicholas Borcherding, Wooseob Kim, Michael Quinn, et al.
Nature Immunology (2024) Vol. 25, Iss. 9, pp. 1731-1741
Open Access | Times Cited: 6

Interleukin-1 Receptor Antagonist Gene (IL1RN) Variants Modulate the Cytokine Release Syndrome and Mortality of COVID-19
Mukundan Attur, Christopher M. Petrilli, Samrachana Adhikari, et al.
The Journal of Infectious Diseases (2024) Vol. 229, Iss. 6, pp. 1740-1749
Open Access | Times Cited: 5

High expression of oleoyl-ACP hydrolase underpins life-threatening respiratory viral diseases
Xiaoxiao Jia, Jeremy Chase Crawford, Deborah Gebregzabher, et al.
Cell (2024) Vol. 187, Iss. 17, pp. 4586-4604.e20
Open Access | Times Cited: 5

ZBP1-driven cell death in severe influenza
David F. Boyd, Summer Vaughn Jordan, Siddharth Balachandran
Trends in Microbiology (2025)
Closed Access

Programmed cell death markers in COVID-19 survivors with and without sepsis
Chandra Shekar Mallarpu, Srinivasa Ikswaja Chelluri, Tapaswi Krishna Katragadda, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Regulation of miRNA in Cytokine Storm (CS) of COVID‐19 and Other Viral Infection: An Exhaustive Review
Chiranjib Chakraborty, Manojit Bhattacharya, Arpita Das, et al.
Reviews in Medical Virology (2025) Vol. 35, Iss. 2
Closed Access

Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology
Andrew H. Karaba, Weiqiang Zhou, Leon L. Hsieh, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 2, pp. 254-262
Open Access | Times Cited: 37

Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection
Michael J. Christie, Aaron T. Irving, Samuel C. Forster, et al.
Science Immunology (2021) Vol. 6, Iss. 63
Open Access | Times Cited: 37

Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
Rajeev K. Singla, Xuefei He, Hitesh Chopra, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients
Stéphanie Bibert, Nicolas Guex, João Lourenço, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33

ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19
Maik Pietzner, Robert Lorenz Chua, Eleanor Wheeler, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 26

Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients
Jorge Monserrat, Ana M. Gómez-Lahoz, Miguel Á. Ortega, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10344-10344
Open Access | Times Cited: 23

Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19
Shiyu Liu, Wenjuan Luo, Peter Szatmary, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3246-3246
Open Access | Times Cited: 14

A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations
Etheresia Pretorius, Douglas B. Kell
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 04, pp. 537-551
Open Access | Times Cited: 14

Pathophysiology of the Acute Respiratory Distress Syndrome
Pratik Sinha, Lieuwe D. J. Bos
Critical Care Clinics (2021) Vol. 37, Iss. 4, pp. 795-815
Open Access | Times Cited: 30

Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19
Vanessa Chilunda, Pablo Martínez-Aguado, Xiaoling Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 28

Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19
Daniel Reynolds, Cristina Vazquez Guillamet, Aaron Day, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 5, pp. 1229-1238
Open Access | Times Cited: 28

The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations
Francisco J. Barrantes
Brain Behavior & Immunity - Health (2021) Vol. 14, pp. 100251-100251
Open Access | Times Cited: 27

Scroll to top